CN105535783B - 一种用于哺乳期妇女回乳的药物及其制备方法 - Google Patents
一种用于哺乳期妇女回乳的药物及其制备方法 Download PDFInfo
- Publication number
- CN105535783B CN105535783B CN201511027885.5A CN201511027885A CN105535783B CN 105535783 B CN105535783 B CN 105535783B CN 201511027885 A CN201511027885 A CN 201511027885A CN 105535783 B CN105535783 B CN 105535783B
- Authority
- CN
- China
- Prior art keywords
- parts
- delaactation
- breast feeding
- feeding women
- drug
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000003814 drug Substances 0.000 title claims abstract description 40
- 210000000481 breast Anatomy 0.000 title claims abstract description 27
- 229940079593 drug Drugs 0.000 title claims abstract description 26
- 238000002360 preparation method Methods 0.000 title claims abstract description 16
- 239000000463 material Substances 0.000 claims abstract description 25
- 239000006071 cream Substances 0.000 claims abstract description 22
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 claims abstract description 17
- 235000006140 Raphanus sativus var sativus Nutrition 0.000 claims abstract description 14
- 238000001035 drying Methods 0.000 claims abstract description 14
- 235000002555 Citrus medica var sarcodactylis Nutrition 0.000 claims abstract description 13
- 240000007126 Citrus medica var. sarcodactylis Species 0.000 claims abstract description 13
- 210000003038 endothelium Anatomy 0.000 claims abstract description 13
- 241001127714 Amomum Species 0.000 claims abstract description 12
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 30
- 235000019441 ethanol Nutrition 0.000 claims description 18
- 239000002994 raw material Substances 0.000 claims description 18
- 241000220259 Raphanus Species 0.000 claims description 13
- 239000006228 supernatant Substances 0.000 claims description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 12
- 238000004140 cleaning Methods 0.000 claims description 6
- 238000001816 cooling Methods 0.000 claims description 6
- 239000012153 distilled water Substances 0.000 claims description 6
- 238000002156 mixing Methods 0.000 claims description 6
- 238000012856 packing Methods 0.000 claims description 6
- 238000007789 sealing Methods 0.000 claims description 6
- 238000003756 stirring Methods 0.000 claims description 6
- 238000003860 storage Methods 0.000 claims description 6
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 claims description 4
- 229920001353 Dextrin Polymers 0.000 claims description 4
- 239000004375 Dextrin Substances 0.000 claims description 4
- 229920002472 Starch Polymers 0.000 claims description 4
- 239000011230 binding agent Substances 0.000 claims description 4
- 235000019425 dextrin Nutrition 0.000 claims description 4
- 238000004519 manufacturing process Methods 0.000 claims description 4
- 239000008107 starch Substances 0.000 claims description 4
- 235000019698 starch Nutrition 0.000 claims description 4
- 229930195727 α-lactose Natural products 0.000 claims description 4
- 241000209140 Triticum Species 0.000 claims description 3
- 235000021307 Triticum Nutrition 0.000 claims description 3
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 claims description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 claims description 2
- 239000002245 particle Substances 0.000 claims description 2
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 claims description 2
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 12
- 238000000034 method Methods 0.000 abstract description 8
- 230000001225 therapeutic effect Effects 0.000 abstract description 2
- 239000008187 granular material Substances 0.000 abstract 2
- 244000088415 Raphanus sativus Species 0.000 abstract 1
- 231100000331 toxic Toxicity 0.000 abstract 1
- 230000002588 toxic effect Effects 0.000 abstract 1
- 210000000952 spleen Anatomy 0.000 description 15
- 210000002784 stomach Anatomy 0.000 description 10
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 8
- 230000008901 benefit Effects 0.000 description 6
- 230000006651 lactation Effects 0.000 description 6
- 235000013336 milk Nutrition 0.000 description 6
- 239000008267 milk Substances 0.000 description 6
- 210000004080 milk Anatomy 0.000 description 6
- 235000013339 cereals Nutrition 0.000 description 5
- 210000004185 liver Anatomy 0.000 description 5
- 230000028327 secretion Effects 0.000 description 5
- 229940011871 estrogen Drugs 0.000 description 4
- 239000000262 estrogen Substances 0.000 description 4
- 230000001737 promoting effect Effects 0.000 description 4
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 4
- 238000007086 side reaction Methods 0.000 description 4
- 239000011726 vitamin B6 Substances 0.000 description 4
- 235000019158 vitamin B6 Nutrition 0.000 description 4
- 229940011671 vitamin b6 Drugs 0.000 description 4
- 102000003946 Prolactin Human genes 0.000 description 3
- 108010057464 Prolactin Proteins 0.000 description 3
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 3
- 238000001467 acupuncture Methods 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 230000029087 digestion Effects 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 239000010446 mirabilite Substances 0.000 description 3
- 230000000474 nursing effect Effects 0.000 description 3
- 229940097325 prolactin Drugs 0.000 description 3
- 230000004206 stomach function Effects 0.000 description 3
- 241000721047 Danaus plexippus Species 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 208000002193 Pain Diseases 0.000 description 2
- OZVBMTJYIDMWIL-AYFBDAFISA-N bromocriptine Chemical compound C1=CC(C=2[C@H](N(C)C[C@@H](C=2)C(=O)N[C@]2(C(=O)N3[C@H](C(N4CCC[C@H]4[C@]3(O)O2)=O)CC(C)C)C(C)C)C2)=C3C2=C(Br)NC3=C1 OZVBMTJYIDMWIL-AYFBDAFISA-N 0.000 description 2
- 229960002802 bromocriptine Drugs 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 description 2
- 210000000750 endocrine system Anatomy 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 230000004936 stimulating effect Effects 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- JLTCWSBVQSZVLT-CDIPANDDSA-N (2s)-n-[(2s)-6-amino-1-[(2-amino-2-oxoethyl)amino]-1-oxohexan-2-yl]-1-[(4r,7s,10s,13s,16s,19r)-19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosan Chemical compound NCCCC[C@@H](C(=O)NCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H]1NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC=2C=CC=CC=2)NC(=O)[C@H](CC=2C=CC(O)=CC=2)NC(=O)[C@@H](N)CSSC1.C([C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CSSC[C@@H](C(N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N1)=O)N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)C1=CC=CC=C1 JLTCWSBVQSZVLT-CDIPANDDSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- UYIFTLBWAOGQBI-BZDYCCQFSA-N Benzhormovarine Chemical compound C([C@@H]1[C@@H](C2=CC=3)CC[C@]4([C@H]1CC[C@@H]4O)C)CC2=CC=3OC(=O)C1=CC=CC=C1 UYIFTLBWAOGQBI-BZDYCCQFSA-N 0.000 description 1
- 102000015554 Dopamine receptor Human genes 0.000 description 1
- 108050004812 Dopamine receptor Proteins 0.000 description 1
- RSEPBGGWRJCQGY-RBRWEJTLSA-N Estradiol valerate Chemical compound C1CC2=CC(O)=CC=C2[C@@H]2[C@@H]1[C@@H]1CC[C@H](OC(=O)CCCC)[C@@]1(C)CC2 RSEPBGGWRJCQGY-RBRWEJTLSA-N 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010054949 Metaplasia Diseases 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 102000005320 Posterior Pituitary Hormones Human genes 0.000 description 1
- 108010070873 Posterior Pituitary Hormones Proteins 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- RGLYKWWBQGJZGM-ISLYRVAYSA-N diethylstilbestrol Chemical compound C=1C=C(O)C=CC=1C(/CC)=C(\CC)C1=CC=C(O)C=C1 RGLYKWWBQGJZGM-ISLYRVAYSA-N 0.000 description 1
- 229960000452 diethylstilbestrol Drugs 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 229960003638 dopamine Drugs 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 229960004766 estradiol valerate Drugs 0.000 description 1
- 206010016766 flatulence Diseases 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 239000002398 materia medica Substances 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000015689 metaplastic ossification Effects 0.000 description 1
- 230000000116 mitigating effect Effects 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000001817 pituitary effect Effects 0.000 description 1
- 230000005195 poor health Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- MKELYWOVSPVORM-DTWKUNHWSA-N reposal Chemical compound C([C@@H]1CC[C@@H](C1)C=1)C=1C1(CC)C(=O)NC(=O)NC1=O MKELYWOVSPVORM-DTWKUNHWSA-N 0.000 description 1
- 229960001472 reposal Drugs 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 230000009291 secondary effect Effects 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
- A61K36/8998—Hordeum (barley)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/57—Birds; Materials from birds, e.g. eggs, feathers, egg white, egg yolk or endothelium corneum gigeriae galli
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9064—Amomum, e.g. round cardamom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
一种用于哺乳期妇女回乳的药物及其制备方法,它涉及一种哺乳期妇女回乳的药物及其制备方法。本发明解决了现有用于治疗哺乳期妇女回乳问题的药物治疗效果差、有副作用的问题。本发明中药颗粒由炒麦芽,生麦芽,鸡内金,阳春砂,佛手片,莱菔子,六神曲和辅料。方法:一、称重;二、漂洗干燥;三、煎煮;四、制膏;五、制粒,干燥即得到中药颗粒。本发明的用于哺乳期妇女回乳,其治疗效果好,安全无毒副作用。
Description
技术领域
本发明涉及一种中药制剂及其制备方法,具体涉及一种用于哺乳期妇女回乳的药物及其制备方法。
背景技术
哺乳期妇女体质多虚。一者妇人生产,耗气伤血,又往往恶露难尽,瘀阻胞宫,气血不畅,短期难以恢复;二者照顾幼儿,白天劳力劳神,夜间亦不得安卧,频频起夜,长此以往,身心俱疲,情志易受影响;三者若选择母乳喂养,实际上是一人负担两人的营养需求,如不注意饮食休息,易导致哺乳者身体虚弱。在诸般虚证中,又以脾胃虚弱之证常见。脾胃为气血生化之源,也是乳汁化生的源头所在。脾胃功能虚弱,会使乳汁的生成排泄失司,导致无法正常回奶。情志不畅,肝气不舒,气滞不行,或脾虚失运,湿阻乳络,都会使乳汁郁积在乳房中,胀痛难忍。
哺乳期妇女回乳是一个必然的过程。正常哺乳10~12个月者,常可自然回乳;若因疾病、正常回乳而乳汁分泌过多或某些特殊原因需要提前回乳的,则往往采用人工回乳的方法。目前常采用的人工回乳方法大致可分为西医、中医、中西医结合三种,再细分,又有外用、内服之别。其中,西医常用内服药物有雌激素类(戊酸雌二醇、乙烯雌酚等)、维生素B6、垂体激素抑制剂(溴隐亭)等,另有激素类针剂(苯甲酸雌二醇)可供选择。雌激素类药物的回乳原理主要是大剂量雌激素能够抑制催乳素的分泌,其缺点在于易扰乱人体的内分泌系统;溴隐亭主要是直接抑制垂体前叶催乳素的分泌,而不影响其他垂体激素,其缺点在于副作用多,常见不良反应有恶心、头痛、眩晕、疲倦、腹痛等,甚至有可能导致终身无法再哺乳。关于维生素B6的回乳原理尚存分歧,一方面有人认为维生素B6能促进脑内多巴胺的生成,从而激动多巴胺受体而减少催乳素的分泌;另一方面有人认为单纯使用维生素B6并无回乳作用,它与雌激素类药物合用主要是为了减轻激素类药物的副反应。不管是何原理,它都存在口服量大、起效不甚明显的缺点。中医回乳主要有内服汤药、外敷芒硝以及针灸三种。民间最多见单用一味炒麦芽煎汤口服回乳,疗效颇佳,但单味药的运用往往忽视了每位哺乳期妇女的体质差异,在一定程度上违背了中医辨证论治的思想。芒硝外敷回乳是取其润燥软坚,清火消肿之功效,然脾胃虚寒者需慎用。针灸回乳取穴有足三里、内关等,缺点为疗程较长。本发明所呈现的是一种以生炒麦芽为君药的中药配方,各种药物配合使用,更能贴近哺乳期妇女的生理特点。
发明内容
本发明的目的在于克服现有技术的不足,提供一种疗效显著,更能贴近哺乳期妇女的生理特点的哺乳期妇女回乳的药物及其制备方法。
技术方案
为实现上述目的,本发明提供一种用于哺乳期妇女回乳的药物由炒麦芽3份-6份,生麦芽3份-6份,鸡内金1份-3份,阳春砂1份-3份,佛手片1份-3份,莱菔子1份-3份,六神曲2份-5份和辅料8-10份制成;辅料为可溶性淀粉、α—乳糖、糊精和黏合剂。
进一步的,一种哺乳期妇女回乳的药物由炒麦芽4份-6份,生麦芽4份-6份,鸡内金2份-3份,阳春砂2份-3份,佛手片2份-3份,莱菔子2份-3份,六神曲3份-5份和辅料8.5-10份制成。
进一步的,一种用于哺乳期妇女回乳的药物由炒麦芽5份,生麦芽5份,鸡内金2份,阳春砂2份,佛手片2份,莱菔子2份,六神曲4份和辅料9份制成。
进一步的,所述辅料中可溶性淀粉、α—乳糖、糊精,比例为3:1:1,所述黏合剂为0.3%羧甲基纤维素钠。
一种用于哺乳期妇女回乳的药物的制备方法,其制备步骤包括如下:
(1)称重:按照重量份配比称取相应原料组分备用;
(2)漂洗干燥:将所称重的原料用蒸馏水洗涤三次,置于清洁环境,日光晒干;
(3)煎煮:将晒干后的原料混合,按照与水的重量比为1︰4,煎煮三次,第一次2-3小时,第二、三次各1.4~1.7小时,合并煎液,滤过,静置;
(4)制膏:取步骤(2)中的上清液,放至室温冷却,加乙醇使含醇量达80%,搅匀,静置,取上清液,回收乙醇,浓缩成相对密度为2.5的清膏,可密封至4℃冰箱冷藏保存;
(5)制粒:取步骤(3)中的清膏,加入辅料,辅料需与浸膏按5:1的比例混合,制成颗粒,干燥,混匀,过12目筛,即得湿颗粒。将湿颗粒于55℃电热恒温干燥箱中干燥至水分少于3%,制得干颗粒。
进一步的,将制成的干颗粒过16目筛,密封分装。
本发明中含有炒麦芽、生麦芽、鸡内金、莱菔子、六神曲、阳春砂、佛手片、莱菔子,麦芽药性甘平,归脾胃肝经,有回乳消胀之功。炒麦芽行气消食回乳,常用于妇女断乳;生麦芽健脾和胃,疏肝行气,常用于乳汁郁积。现代药理研究发现,麦芽具有催乳和回乳的双向作用,其作用关键不在于生用或炒用,而在于剂量的大小,小剂量时催乳,大剂量时回乳,本发明中用了大量等份的生炒麦芽,取其回乳之功效。鸡内金性甘平,归脾胃经,临床广泛运用于米面薯芋乳肉等各种积滞证,有健脾和胃行乳之效。六神曲性甘辛温,归脾胃经,有消食和胃之功。莱菔子性辛甘平,归肺脾胃经,有消食除胀、降气化痰之效,行气之力尤佳。阳春砂性辛温,归脾胃肾经,有化湿开胃温脾理气之功。佛手片性辛苦酸温,归肝脾胃肺经,具疏肝理气,和胃止痛,燥湿化痰之功效。
本发明中以回乳消胀之炒、生麦芽为君,以健脾消食和胃之鸡内金、六神曲、莱菔子为臣,并佐以健脾理气之阳春砂,疏肝行气之佛手片。与常见西医回乳手段相比,本发明具有极少影响内分泌系统、不影响再次哺乳、副反应小的优势;与民间常用单味炒麦芽回乳相比,具有全面照顾哺乳期妇女体质特点、注重肝脾调护的优势;与虚寒者慎用的芒硝外敷法相比,具有使用人群范围更广的优势;与针灸回乳相比,具有疗程短、无创伤的优势。
下面结合具体实施例对本发明作进一步的说明,下述该实施例仅用于说明本发明而对本发明没有限制。
实施例1
一种用于哺乳期妇女回乳的药物,由炒麦芽5份,生麦芽5份,鸡内金2份,阳春砂2份,佛手片2份,莱菔子2份,六神曲4份和辅料9份制成。
其制备步骤包括如下:
(1)称重:按照重量份配比称取相应原料组分备用;
(2)漂洗干燥:将所称重的原料用蒸馏水洗涤三次,置于清洁环境,日光晒干;
(3)煎煮:将晒干后的原料混合,按照与水的重量比为1︰4,煎煮三次,第一次2.5小时,第二、三次各1.5小时,合并煎液,滤过,静置;
(4)制膏:取步骤(2)中的上清液,放至室温冷却,加乙醇使含醇量达80%,搅匀,静置,取上清液,回收乙醇,浓缩成相对密度为2.5的清膏,可密封至4℃冰箱冷藏保存;
(5)制粒:取步骤(3)中的清膏,加入辅料,辅料需与浸膏按5:1的比例混合,制成颗粒,干燥,混匀,过12目筛,即得湿颗粒。将湿颗粒于55℃电热恒温干燥箱中干燥至水分少于3%,制得干颗粒,将制成的干颗粒过16目筛,密封分装。
实施例2
一种用于哺乳期妇女回乳的药物,由炒麦芽3份,生麦芽3份,鸡内金1份,阳春砂1份,佛手片1份,莱菔子1份,六神曲2份和8份的辅料制成。
其制备步骤包括如下:
(1)称重:按照重量份配比称取相应原料组分备用;
(2)漂洗干燥:将所称重的原料用蒸馏水洗涤三次,置于清洁环境,日光晒干;
(3)煎煮:将晒干后的原料混合,按照与水的重量比为1︰4,煎煮三次,第一次2小时,第二、三次各1.4小时,合并煎液,滤过,静置;
(4)制膏:取步骤(2)中的上清液,放至室温冷却,加乙醇使含醇量达80%,搅匀,静置,取上清液,回收乙醇,浓缩成相对密度为2.5的清膏,可密封至4℃冰箱冷藏保存;
(5)制粒:取步骤(3)中的清膏,加入辅料,辅料需与浸膏按5:1的比例混合,制成颗粒,干燥,混匀,过12目筛,即得湿颗粒。将湿颗粒于55℃电热恒温干燥箱中干燥至水分少于3%,制得干颗粒,将制成的干颗粒过16目筛,密封分装。
实施例3
一种用于哺乳期妇女回乳的药物,由炒麦芽6份,生麦芽6份,鸡内金3份,阳春砂3份,佛手片3份,莱菔子3份,六神曲5份和10份的辅料制成。
其制备步骤包括如下:
(1)称重:按照重量份配比称取相应原料组分备用;
(2)漂洗干燥:将所称重的原料用蒸馏水洗涤三次,置于清洁环境,日光晒干;
(3)煎煮:将晒干后的原料混合,按照与水的重量比为1︰4,煎煮三次,第一次3小时,第二、三次各1.7小时,合并煎液,滤过,静置;
(4)制膏:取步骤(2)中的上清液,放至室温冷却,加乙醇使含醇量达80%,搅匀,静置,取上清液,回收乙醇,浓缩成相对密度为2.5的清膏,可密封至4℃冰箱冷藏保存;
(5)制粒:取步骤(3)中的清膏,加入辅料,辅料需与浸膏按5:1的比例混合,制成颗粒,干燥,混匀,过12目筛,即得湿颗粒。将湿颗粒于55℃电热恒温干燥箱中干燥至水分少于3%,制得干颗粒,将制成的干颗粒过16目筛,密封分装。
实施例4
一种用于哺乳期妇女回乳的药物,由炒麦芽5份,生麦芽4份,鸡内金2份,阳春砂2份,佛手片1份,莱菔子2份,六神曲5份和7份的辅料制成。
其制备步骤包括如下:
(1)称重:按照重量份配比称取相应原料组分备用;
(2)漂洗干燥:将所称重的原料用蒸馏水洗涤三次,置于清洁环境,日光晒干;
(3)煎煮:将晒干后的原料混合,按照与水的重量比为1︰4,煎煮三次,第一次2.7小时,第二、三次各1.6小时,合并煎液,滤过,静置;
(4)制膏:取步骤(2)中的上清液,放至室温冷却,加乙醇使含醇量达80%,搅匀,静置,取上清液,回收乙醇,浓缩成相对密度为2.5的清膏,可密封至4℃冰箱冷藏保存;
(5)制粒:取步骤(3)中的清膏,加入辅料,辅料需与浸膏按5:1的比例混合,制成颗粒,干燥,混匀,过12目筛,即得湿颗粒。将湿颗粒于55℃电热恒温干燥箱中干燥至水分少于3%,制得干颗粒,将制成的干颗粒过16目筛,密封分装。
实施例5
2010.9—2015.9浙江省中医院乳腺科就诊总人数为7046人,因哺乳期回乳问题前来就诊的有699人,将有回乳问题的人用本发明药物(二麦回乳颗粒)治疗的有579人,治疗后有效回乳的有547人,有效率为94.4%。
表1
各种回乳方式有效率及副反应发生率统计表
注:有效是指使用各回乳方法后在12天内回乳成功。
副反应是指各西药药物说明上所陈述的款项。
表1中的数据说明,本发明的回乳药物对哺乳期的哺乳问题治疗效果好,有效率为94%,且无副反应发生,安全可靠。
根据本发明所公开的内容,本领域技术人员可最大限度地应用本发明。因此,上述优选具体实施方式仅是举例说明,而非以任何方式限制本发明的范围。
Claims (5)
1.一种用于哺乳期妇女回乳的药物,其特征在于,用于哺乳期妇女回乳的药物由炒麦芽4份-6份,生麦芽4份-6份,鸡内金2份-3份,阳春砂2份-3份,佛手片2份 -3份,莱菔子2份-3份,六神曲3份-5份和辅料8.5-10份制成;辅料为可溶性淀粉、α—乳糖、糊精和黏合剂,其中可溶性淀粉、α—乳糖、糊精,比例为3:1:1,所述黏合剂为0.3%羧甲基纤维素钠。
2.根据权利要求1所述一种用于哺乳期妇女回乳的药物,其特征在于,用于哺乳期妇女回乳的 药物由炒麦芽5份,生麦芽5份,鸡内金2份,阳春砂2份,佛手片2份,莱菔子2份,六神曲4份和辅料9份制成。
3.一种权利要求1所述的用于哺乳期妇女回乳的药物制备方法,其特征在于其制备步骤如下:
(1)称重:按照重量份配比称取相应原料组分备用;
(2)漂洗干燥:将所称重的原料用蒸馏水洗涤三次,置于清洁环境,日光晒干;
(3)煎煮:将晒干后的原料混合,按照与水的重量比为1︰4,煎煮三次,第一次2-3小时,第二、三次各1.4~1.7小时,合并煎液,滤过,静置;
(4)制膏:取步骤(2)中的上清液,放至室温冷却,加乙醇使含醇量达80%,搅匀,静置,取上清液,回收乙醇,浓缩成相对密度为2.5的清膏,可密封至4℃冰箱冷藏保存;
(5)制粒:取步骤(3)中的清膏,加入辅料,辅料需与浸膏按5:1的比例混合,制成颗粒,干 燥,混匀,过12目筛,即得湿颗粒;将湿颗粒于55℃电热恒温干燥箱中干燥至水分少于3%, 制得干颗粒。
4.根据权利要求3所述的一种用于哺乳期妇女回乳的药物制备方法,其特征在于,将制成的 干颗粒过16目筛,密封分装。
5.根据权利要求3所述的一种用于哺乳期妇女回乳的药物制备方法,其特征在于,所述制备 步骤(4)中煎煮三次,第一次2.5小时,第二、三次各1.5小时。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201511027885.5A CN105535783B (zh) | 2015-12-31 | 2015-12-31 | 一种用于哺乳期妇女回乳的药物及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201511027885.5A CN105535783B (zh) | 2015-12-31 | 2015-12-31 | 一种用于哺乳期妇女回乳的药物及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105535783A CN105535783A (zh) | 2016-05-04 |
CN105535783B true CN105535783B (zh) | 2019-03-08 |
Family
ID=55815666
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201511027885.5A Active CN105535783B (zh) | 2015-12-31 | 2015-12-31 | 一种用于哺乳期妇女回乳的药物及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105535783B (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110384776A (zh) * | 2019-08-06 | 2019-10-29 | 徐州市孕美汇生物科技有限公司 | 一种回乳中药颗粒及其制备方法 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101757484A (zh) * | 2008-11-12 | 2010-06-30 | 孙延明 | 一种用于产后回乳的中药 |
-
2015
- 2015-12-31 CN CN201511027885.5A patent/CN105535783B/zh active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101757484A (zh) * | 2008-11-12 | 2010-06-30 | 孙延明 | 一种用于产后回乳的中药 |
Non-Patent Citations (1)
Title |
---|
生麦芽炒麦芽与催乳回乳关系的探讨;尹青青等;《时珍国医国药》;20021231;第13卷(第03期);162-163 |
Also Published As
Publication number | Publication date |
---|---|
CN105535783A (zh) | 2016-05-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102178912B (zh) | 用于阳虚体质的人缓解胃脘冷痛症状的中药制剂及其制备方法和应用 | |
CN104162094B (zh) | 一种治疗肥胖型多囊卵巢综合征的中药组合物及其药物制剂 | |
CN102178911B (zh) | 用于阳虚、痰湿体质人祛风除湿、通络止痛的中药制剂及其制备方法和应用 | |
CN103099206A (zh) | 一种营养保健粥粉及其制作方法 | |
CN106943523A (zh) | 用于调节内分泌失调的中药组合物及制备方法 | |
CN101612279A (zh) | 一种促进骨折愈合的中药制剂 | |
CN105535783B (zh) | 一种用于哺乳期妇女回乳的药物及其制备方法 | |
CN106490558A (zh) | 一种保健蜂蜜及其制备方法 | |
CN101152396B (zh) | 五子参芪滋补蜜丸及其制备工艺 | |
CN1294949C (zh) | 治疗性功能障碍、月经不调、不育症和增强免疫功能的中药制剂 | |
CN114224963A (zh) | 一种用于增强免疫力缓解体力疲劳的中药制剂及其制备方法 | |
CN102178870B (zh) | 用于气郁体质、痰湿体质人行气活血、软坚散结的中药制剂及其制备方法和应用 | |
CN101934046B (zh) | 一种鹿胎膏及其制备方法 | |
CN104689239A (zh) | 一种治疗胆石症的中药组合物及其制备方法 | |
CN104784604A (zh) | 锁阳酒及其制备方法 | |
CN104367726A (zh) | 一种降血糖益气血调眠茶及其生产方法 | |
CN103637203A (zh) | 一种莲子补脑健脑汤料的配方及生产方法 | |
CN104173521B (zh) | 一种生精壮阳的药物组合物及其制备方法 | |
CN108542946B (zh) | 一种具有减肥功能的中药方剂及其制备方法 | |
CN106729409A (zh) | 一种用于儿童腹股沟疝护理的中药组合物 | |
CN104740013A (zh) | 一种治疗恶性肿瘤的中药组合物 | |
CN104784587A (zh) | 一种治疗内分泌失调型不孕的中药组合物及其制备方法 | |
CN104474381B (zh) | 一种回乳的中药组合物及其应用 | |
CN113679800A (zh) | 桑叶黄精补肾膏及其制备方法 | |
CN1318042C (zh) | 半支莲在制备治疗糖尿病药物方面的用途 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |